UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

Annals of oncology, 2010-06, Vol.21 (6), p.1254-1261

2010

Link zum Volltext

Verfügbarkeit prüfen

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Oncogene, 2013-04, Vol.32 (14), p.1821-1830

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

British journal of cancer, 2013-05, Vol.108 (10), p.2039-2044

2013

Link zum Volltext

Verfügbarkeit prüfen

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

British journal of cancer, 2012-05, Vol.106 (11), p.1779-1789

2012

Link zum Volltext

Verfügbarkeit prüfen

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

British journal of cancer, 2010-07, Vol.103 (3), p.401-410

2010

Link zum Volltext

Verfügbarkeit prüfen

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.725-734

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictive markers in breast cancer - the future

Histopathology, 2008-01, Vol.52 (1), p.91-98

2008

Link zum Volltext

Verfügbarkeit prüfen

Diesel exhaust inhalation increases thrombus formation in man

European heart journal, 2008-12, Vol.29 (24), p.3043-3051

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

European journal of cancer (1990), 2008-02, Vol.44 (3), p.391-399

2008

Link zum Volltext

Verfügbarkeit prüfen

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

Histopathology, 2008-06, Vol.52 (7), p.847-855

2008

Link zum Volltext

Verfügbarkeit prüfen

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.ES8-1-ES8-1

Faratian, D

2010

Link zum Volltext

Verfügbarkeit prüfen

Reply to: Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the ‘self (stem cell)-seeding’ nature of breast cancer disease?

Annals of oncology, 2010-06, Vol.21 (6), p.1375-1375

2010

Link zum Volltext

Verfügbarkeit prüfen

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

International journal of gynecological cancer, 2006-05, Vol.16 (3), p.972-978

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

European journal of cancer (1990), 2008-02, Vol.44 (3), p.391-399

2008

Link zum Volltext

Verfügbarkeit prüfen

Bronchial basal cell and epithelial repair

Thorax, 2004-08, Vol.59 (8), p.693-693

Faratian, D

2004

Link zum Volltext

Verfügbarkeit prüfen

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

International journal of gynecological cancer, 2006-04, Vol.16 (3), p.972-978

2006

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

European journal of cancer supplements, 2008, Vol.6 (7), p.60-60

2008

Link zum Volltext

Verfügbarkeit prüfen

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

European heart journal, 2013-08, Vol.34 (suppl 1), p.P5689-P5689

2013

Link zum Volltext

Verfügbarkeit prüfen

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Journal of obstetrics and gynaecology, 2006-05, Vol.26 (4), p.385-387

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-12

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-07-02

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-02-08

2010

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Annals of oncology, 2012-09, Vol.23, p.ix96

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P5-P5-05-06

2010

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5132-5132

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Englisch
(43)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals

Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

Predictive markers in breast cancer - the future

Diesel exhaust inhalation increases thrombus formation in man

Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

Abstract ES8-1: Systems Biology — Can It Explain Everything?

Reply to: Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the ‘self (stem cell)-seeding’ nature of breast cancer disease?

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer

Bronchial basal cell and epithelial repair

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

Monoclonal antibodies specific for Phospho-4E-BP1 (Thr 70) and phospho-AKT (Ser 473) indicate prognosis in breast cancer

Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis

Ovarian choriocarcinoma masquerading as ectopic pregnancy

Abstract P2-09-12: Phosphoproteomic Pathway Profiling of Breast Cancers for Biomarker and Target Discovery for Personalized Therapy

Abstract P6-07-02: A Systems Analysis of Oscillations in the MAPK Pathway Reveals New Mechanisms of Feed-Forward and Feedback Signaling Control

Abstract P4-02-08: STAT Signaling in Endocrine Sensitive and Resistant Breast Cancer — A Potential Target for Therapy?

Proteomic Predictors of Outcome After Adjuvant Anti-Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Abstract P5-05-06: The Role of Sprouty 2 in HER2 Signaling in Breast Cancer; Decreased Expression Is Associated with Poor Outcome Including in Trastuzumab-Treated Patients

Gene Expression Profiles of Endocrine Resistant Breast Tumours

Suchergebnisse filtern